My cart
In the shopping cart is not goods, to choose and buy!
  • Product Name
  • Size
  • Quantity
  • Amount
    Selected items : 0 pieces Total : CHECK OUT()
    Dexmedetomidine
    Dexmedetomidine

    Price:
    Market Price:

    This product is for research use only, not for human use. We do not sell to patients.
    Number: - + Pieces(InventoryPieces)
    InvivoChem Cat #: V1146
    CAS #: 113775-47-6Purity ≥98%

    Description: Dexmedetomidine (trade name Precedex), the dexter isomer of medetomidine, is a potent and highly selective alpha-2 adrenergic receptor agonist with sedative activities. Dexmedetomidine reduces anesthetic requirements for patients by providing significant sedation.  

    References: Eur J Pharmacol. 1988 May 20;150(1-2):9-14; Anesthesiology. 1997 Feb;86(2):331-45.

    elated CAS #: 145108-58-3 (HCl)   113775-47-6 (free base)   

    Customer Validation
    Official Supplier of
    • VE
    • OF
    • YALE
    • hhmi
    • 香港大学
    Related Products
    Publications Citing InvivoChem Products
    • Physicochemical and Storage Information
    • Protocol
    • Quality Control Documentation
    • Related Biological Data
    • Customer Review
    Molecular Weight (MW)200.28
    FormulaC13H16N2 
    CAS No.113775-47-6 
    Storage-20℃ for 3 years in powder form
    -80℃ for 2 years in solvent
    Solubility (In vitro)DMSO: 40 mg/mL (199.7 mM) 
    Water: 40 mg/mL (199.7 mM) 
    Ethanol: 40 mg/mL (199.7 mM) 
    Other info

    Chemical Name: 5-[(1S)-1-(2,3-dimethylphenyl)ethyl]-1H-imidazole

    InChi Key: CUHVIMMYOGQXCV-NSHDSACASA-N

    InChi Code: InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1

    SMILES Code: CC1=C(C(=CC=C1)[[email protected]](C)C2=CN=CN2)C

    SynonymsDexmedetomidine HCl; Dexmedetomidine Hydrochloride; Precedex; 


    • Molarity Calculator
    • Dilution Calculator
    • The molarity calculator equation

      Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

      • Mass
      • Concentration
      • Volume
      • Molecular Weight *
      • =
      • ×
      • ×
    • The dilution calculator equation

      Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

      This equation is commonly abbreviated as: C1V1 = C2V2

      • Concentration (start)
      • ×
      • Volume (start)
      • =
      • Concentration (final)
      • ×
      • Volume (final)
      • ×
      • =
      • ×
      • C1
      •  
      • V1
      •  
      • C2
      •  
      • V2
    In Vitro

    In vitro activity: Dexmedetomidine has a relatively high ratio of α2/α1-activity (1620:1 as compared with 220:1 for clonidine) and, therefore, is considered a full agonist of the α2 receptor. This may result in more potent effects of sedation without unwanted cardiovascular effects from α1 receptor activation. The 2-h half-life of dexmedetomidine is nearly 4-fold shorter than that of clonidine, which increases the likelihood that a continuous infusion of dexmedetomidine might be useful for sedation. Dexmedetomidine also has minimum alveolar anesthetic concentration (MAC)-sparing properties, but its use as an anesthetic adjuvant has been complicated by persistent hypotension that has mandated IV fluid administration and vasopressor administration. In addition, its use in large doses is complicated by hypertension from α2 receptor-mediated vascular constriction.

    In Vivo
    Animal model
    Formulation & Dosage
    References

    Eur J Pharmacol. 1988 May 20;150(1-2):9-14; Anesthesiology. 1997 Feb;86(2):331-45. 


    These protocols are for reference only. InvivoChem does not independently validate these methods.

    Dexmedetomidine
    Immunofluorescence staining of phosphorylated ERK1/2 in astrocyte cultures. Br J Pharmacol. 2008 May; 154(1): 191–203.


    Dexmedetomidine
    Src kinase is involved in dexmedetomidine-induced, but not EGF-induced ERK1/2 phosphorylation in astrocytes. Br J Pharmacol. 2008 May; 154(1): 191–203.



    Dexmedetomidine
    Dexmedetomidine-induced protein expression of cFos and FosB requires EGF receptor and ERK action in astrocytes. Br J Pharmacol. 2008 May; 154(1): 191–203.


    评论

      Home Prev Next Last page / pices

      发评论

      ×
      Your information is safe with us. * Required Fields.
      Products are for research use only;  We do not sell to patients
      Tel: 1-708-310-1919
      Fax: 1-708-557-7486
      Subscribe to our E-newsletter
      • Name*
      • *
      • E-mail*
      • *
      • instructions:
      • *
      Copyright 2020 InvivoChem LLC | All Rights Reserved
      prompt
      Do you confirm the receipt?